SPARC Announces Major Workforce Reduction, Shifts to Hybrid R&D Model
Sun Pharma Advanced Research Company Ltd. (SPARC) has announced plans to reduce its workforce by around 40% as part of a broader restructuring aimed at streamlining operations and optimising costs. The impact will be most pronounced in the United States, where more than 80% of employees are expected to be laid off, according to company disclosures.
Pharma Layoff | 09/01/2026 | By Darshana
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy